← Leaderboards
Ivonne H Schulman
University Of Miami School Of Medicine
$1,007,245
Attributed
$2,014,490
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $687.4K · FY2016–18$1M$750K$500K$250K$0
'16
'17
'18
Funding mix
By agency
NIH$2,014,490 · 1
By mechanism
R01$2,014,490 · 1
Top collaborators
- Joshua M Hare3 shared
Most similar at University Of Miami School Of Medicine
Same institution · by research overlap
- Danuta Szczesna-Cordary$10,536,169
- Roberto Irenardo Vazquez Padron$5,595,653
- Eckhard R Podack$11,788,352
- Bradley J Goldstein$6,362,477
- Byron L Lam$1,733,412
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchAgingAffectAngiogenic FactorAnti-InflammatoryAnti-Inflammatory AgentsAllogenicAftercareBiological MarkersBlood VesselsBone MarrowBone Marrow BiopsyBrachial ArteryCardiacAutologousCardiovascular DiseasesBaseCause Of DeathCell GrowthCell PhysiologyCell TherapyCessation Of LifeClinical InvestigationClinical Trials
Grant awards (3)
Mesenchymal stem cell therapy for endothelial dysfunction in diabetes$687,355
R01 · FY2018 · HL · contact PI
Mesenchymal stem cell therapy for endothelial dysfunction in diabetes$677,730
R01 · FY2017 · HL · contact PI
Mesenchymal stem cell therapy for endothelial dysfunction in diabetes$649,405
R01 · FY2016 · HL · contact PI